RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Hector Biliran to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Hector Biliran has written about Protein Kinase Inhibitors.
Hector Biliran
Connection Strength
1.707
Protein Kinase Inhibitors
  1. Dela Cruz MC, Yao X, Nealy A, Bailey J, Nalls M, Medina PM, Chen R, Biliran H. BIT1 as an Effector of EGFR-TKI-induced Apoptosis via TLE1 Inhibition in Lung Adenocarcinoma Cells. Anticancer Res. 2026 Apr; 46(4):1799-1818.
    View in: PubMed
    Score: 0.878
  2. Dela Cruz MC, Yao X, Roberts N, Iheukwumere P, Carmouche A, Medina PM, Biliran H. TLE1 drives EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma through epithelial to mesenchymal transition. Biochem Biophys Res Commun. 2025 08 15; 775:152146.
    View in: PubMed
    Score: 0.829
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support